Endo unit cleared of liability in first testosterone replacement trial
November 16, 2017 at 16:21 PM EST
NEW YORK, Nov 16 (Reuters) - A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim.